Karen S Lundstedt - Net Worth and Insider Trading

Karen S Lundstedt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karen S Lundstedt owns 1 companies in total, including Ionis Pharmaceuticals Inc (IONS) .

Click here to see the complete history of Karen S Lundstedt’s form 4 insider trades.

Insider Ownership Summary of Karen S Lundstedt

Ticker	Comapny	Transaction Date	Type of Owner
IONS	Ionis Pharmaceuticals Inc	2003-05-09	Vice President

Karen S Lundstedt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Karen S Lundstedt Ownership Network

Ownership Network List of Karen S Lundstedt

No Data

Ownership Network Relation of Karen S Lundstedt

Karen S Lundstedt Owned Company Details

What does Ionis Pharmaceuticals Inc do?

Who are the key executives at Ionis Pharmaceuticals Inc?

Karen S Lundstedt is the Vice President of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include Senior Vice President Richard S Geary , EVP & Corp and Development Ops Brian Birchler , and Chief Business Officer Joseph Baroldi .

Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary

Over the past 18 months, Karen S Lundstedt made no insider transaction in Ionis Pharmaceuticals Inc (IONS). Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 181,397 shares made by Brett P Monia , a net sale of 35,600 shares made by Richard S Geary , and a net sale of 60,168 shares made by C Frank Bennett .

In summary, during the past 3 months, insiders sold 16,718 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 0 shares, with a net sale of 16,718 shares. During the past 18 months, 621,277 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 621,277 shares.

Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ionis Pharmaceuticals Inc Insider Transactions

No Available Data

Karen S Lundstedt Mailing Address

Above is the net worth, insider trading, and ownership report for Karen S Lundstedt. Currently GuruFocus does not have mailing address information for Karen S Lundstedt.

Discussions on Karen S Lundstedt

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.